Mutations identified in the primary FH-causing genes (including LDLR, APOB, PCSK9, and LDLRAP1) show a similar gene dosage effect and share a comparable clinical phenotype, describing a semidominant inheritance pattern (Nordestgaard et al., 2013). The gene discussed is PCSK9; the disease is familial hyperaldosteronism.